Blockchain Registration Transaction Record
ABVC BioPharma Anticipates $19 Million Cash Income from Global Licensing Agreements and CDMO Acquisition
ABVC BioPharma announces $19 million in cash income from global licensing agreements and CDMO acquisition, reinforcing its strategic positioning for long-term growth in psychiatric disorders, ophthalmology, and oncology.

This news matters as ABVC's strategic partnerships and acquisitions demonstrate its commitment to innovation and revenue growth in key therapeutic areas. The $19 million expected income underscores the company's position as a leading player in the global pharmaceutical market, with a strong revenue pipeline set to drive future expansion and value creation.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x9c08993930780a23ad89587b5e496a59223fadb9bd5219c26cd238da619ff728 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | icyEwMS-062795b02ae0e2f3f5395b647952f209 |